대한결핵및호흡기학회 KATRD

GNB 메뉴 보기

KATRD 2019 International Conference
November 7(Thu)-8(Fri), 2019 Lotte Hotel World, Seoul, Kore
Scientific Program

Scientific Program

Program in Detail

[SY01]
Asthma- Session Title : Optimal asthma care
Crystal Ballroom 1
10:30-12:00 Chair: Ho Joo Yoon(Hanyang University)Jung Hyun Chang(Ewha Womans University)
10:30-11:00 Novel treatment strategies for mild asthma Yeon-Mok Oh(University of Ulsan)
11:00-11:30 Optimal selection of inhalers in asthma YONG IL HWANG(Hallym University)
11:30-12:00 Non-T2 asthma: approach and management Ji-yong MOON(Hanyang University)
[SY02]
Asthma– Session Title : Precision medicine in asthma treatment
Crystal Ballroom 1
13:30-15:00 Chair: Hisako Matsumoto(Kyoto University Graduate School of Medicine)Yong Chul Lee(Chonbuk National University)
13:30-14:00 Moving toward precision medicine in severe difficult asthma; a role of serum periostin Hisako Matsumoto(Kyoto University Graduate School of Medicine)
14:00-14:30 Pharmacogenomics in asthma treatment Heung-Woo Park(Seoul National University)
14:30-15:00 Treatment of severe asthma based on treatable traits Mi-Ae Kim(CHA University)
[SY03]
Environmental Lung Disease- Session Title: Hot issues in environmental lung disease in 2019
Crystal Ballroom 1
15:30-17:00 Chair: HyoungKyu Yoon(The Catholic University of Korea)Sung Hwan Jeong(Gachon University)
15:30-16:00 Impact of air pollution on lung function and imaging phenotypes Woo Jin Kim(Kangwon University)
16:00-16:30 Screening for asbestos-related lung cancer HyoungKyu Yoon(The Catholic University of Korea)
16:30-17:00 Humidifier-disinfectants related asthma Jongmin Lee(The Catholic University)
[SY04]
Pulmonary Vascular Disease- Session Title: Updated management of VTE
Crystal Ballroom 2
10:30-12:00 Chair: Sang-Do Lee(University of Ulsan)Byoung Whui Choi(Chung-Ang University)
10:30-11:00 Is it possible to use DOACs in patients with VTE and CRF on HD? Hun Gyu Hwang(Soonchunhyang University)
11:00-11:30 Who would be candidate for long-term management of DOACs? Yee Hyung Kim(Kyung Hee University)
11:30-12:00 Clinical practices to detect and to manage patients with antiphospholipid syndrome and VTE Yong Sub Na(Chosun University)
[SY05]
ILD- Session Title: Update in the management of IPF
Crystal Ballroom 2
13:30-15:00 Chair: Moo Suk Park(Yonsei University)Luca Richeldi(Universita Cattolica del Sacro Cuore)
13:30-14:00 Diagnosis & Treatment of IPF : when to start and when to stop antifibrotics Hye Sook Choi(Kyung Hee University)
14:00-14:30 New emerging phamacological treatment for IPF Luca Richeldi(Universita Cattolica del Sacro Cuore)
14:30-15:00 Acute Exacerbation of IPF: current management and future perspectives Jin Woo Song(University of Ulsan)
[SY06]
ILD- Session Title: Progressive fibrosing ILD beyond IPF
Crystal Ballroom 2
15:30-17:00 Chair: Arata Azuma(Pulmonary Medicine, Nippon Medical School)Sadatomo Tasaka(Hirosaki University School of Medicine)
15:30-16:00 Non-IPF fibrosing ILD Arata Azuma(Pulmonary Medicine, Nippon Medical School)
16:00-16:30 Recent advances in the diagnosis and management of Pneumocystis pneumonia Sadatomo Tasaka(Hirosaki University School of Medicine)
16:30-17:00 Diagnosis and management of patients with CTD-ILD: A single-center experience Yong Hyun Kim(The Catholic University)
[SY07]
Bronchoscopy- Session Title: Endoscopic modalities in chest medicine
Crystal Ballroom 3
10:30-12:00 Chair: Ho Joong Kim(Sungkyunkwan University)Young Kyoon Kim(The Catholic University)
10:30-11:00 Medical thoracoscopic management in pleural diseases Young Sik Park(Seoul National University)
11:00-11:30 EBUS-TBNA and EUS-B; update Bin Hwangbo (National Cancer Center)
11:30-12:00 Bronchoscopic management for emphysema and severe asthma; practical issues and case selection Sei Won Lee(University of Ulsan)
[SY08]
Lung Cancer- Session Title: Coping with ALK rearranged NSCLC
Crystal Ballroom 3
13:30-15:00 Chair: Takashi Seto(National Hospital Organization Kyushu Cancer Center)Kye Young Lee(Konkuk University)
13:30-14:00 What is the best long-term treatment plan for ALK rearranged NSCLC? Takashi Seto(National Hospital Organization Kyushu Cancer Center)
14:00-14:30 Molecular resistance mechanisms of ALK inhibitors Seung Hyeun Lee(Kyung Hee University)
14:30-15:00 Optimal treatment for CNS metastasis of ALK rearranged NSCLC Dong Won Park(Hanyang University)
[SY09]
Lung Cancer- Session Title: New insights and emerging therapies for lung cancer
Crystal Ballroom 3
15:30-17:00 Chair: David Chi-Leung Lam(Hong Kong University)Darren Wan-Teck Lim(National Cancer Center Singapore)
15:30-16:00 Therapeutic biomarkers in lung cancer David Chi-Leung Lam(Hong Kong University)
16:00-16:30 Immunotherapy for NSCLC – addressing heterogeneity Darren Wan-Teck Lim(National Cancer Center Singapore)
16:30-17:00 The journey of immuno-oncology; changing landscape for cancer treatment Natasha Leighl(University of Toronto)
[SY10]
Meet the expert - COPD
Charlotte
10:30-12:00
10:30-12:00 ICS use and blood eosinophils in COPD; precision medicine Dave Singh(University of Manchester)
[SY11]
Meet the expert - Tuberculosis
Charlotte
13:30-15:00
13:30-15:00 The role of new drugs for MDR-TB management Jeffrey S. Hafkin(Otsuka Pharmaceutical Development and Commercialization)
[SY12]
Meet the expert – COPD
Charlotte
15:30-17:00
15:30-17:00 Challenging Questions in COPD Chirstopher Cooper(UCLA Pulmonary Function and Exercise Physiology Research Laboratories)

Go Top

© The Korean Academy of Tuberculosis and Respiratory Diseases

Contact Secretariat of KATRDIC 2019
[04038] 5F, Samgyeong Bldg., #20, Yanghwa-ro, Mapo-gu, Seoul, Korea